Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 170 entries
View as:

As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00382889 Org: User:
Start: 08/31/02 End: 09/30/04 Due: 09/30/05

Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00528723 Org: User:
Start: 11/30/07 End: 01/31/09 Due: 01/31/10

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Multiple Doses in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06746064 Org: User:
Start: 01/13/25 End: 01/15/26 Due: 01/15/27

An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients Using The NEXThaler DPI

Phase: N/A Priority: Normal
NCT ID: NCT02018549 Org: User:
Start: 12/31/13 End: 06/30/14 Due: 06/30/15

beCLomethasone Efficacy in Acute Rhinosinusitis - CLEAR Study

Phase: N/A Priority: Normal
NCT ID: NCT01691677 Org: User:
Start: 01/31/13 End: 01/31/14 Due: 01/31/15

Step-up to Medium Strength Triple Therapy vs High Strength ICS/LABA in Adult Asthmatics Uncontrolled on Medium Strength ICS/LABA

Phase: N/A Priority: Normal
NCT ID: NCT05018598 Org: User:
Start: 02/25/22 End: 04/16/24 Due: 04/16/25

Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Open Label Extension (CT04 OLEP)

Phase: N/A Priority: Normal
NCT ID: NCT01421056 Org: User:
Start: 07/31/11 End: 11/30/12 Due: 11/30/13

A Thorough QT (TQT) Study of CHF5993 pMDI in Healthy Volunteers (HV)

Phase: N/A Priority: Normal
NCT ID: NCT05830071 Org: User:
Start: 03/29/23 End: 10/13/23 Due: 10/13/24

EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI

Phase: N/A Priority: Normal
NCT ID: NCT00394368 Org: User:
Start: 11/30/04 End: 09/30/05 Due: 09/30/06

Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04049175 Org: User:
Start: 08/28/19 End: 02/01/21 Due: 02/01/22

Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children

Phase: N/A Priority: Normal
NCT ID: NCT01450774 Org: User:
Start: 09/30/11 End: 02/28/14 Due: 02/28/15

ARCANGELO (itAlian pRospective Study on CANGrELOr)

Phase: N/A Priority: Normal
NCT ID: NCT04471870 Org: User:
Start: 10/23/20 End: 01/17/22 Due: 01/17/23

Study in Adult Patients With Moderate to Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04886999 Org: User:
Start: 02/24/22 End: 02/01/23 Due: 02/01/24

Cangrelor Neonatal PK/PD and Safety Study

Phase: N/A Priority: Normal
NCT ID: NCT02765633 Org: User:
Start: 01/03/17 End: 12/23/19 Due: 12/23/20

Open-Label Expanded Access Treatment With Pegunigalsidase Alfa for Fabry Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT04552691 Org: User:
Start: - End: - Due: -

Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01398111 Org: User:
Start: 05/31/11 End: 08/31/11 Due: 08/31/12

Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis

Phase: N/A Priority: Normal
NCT ID: NCT04031066 Org: User:
Start: 01/11/21 End: 12/29/21 Due: 12/29/22

Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)

Phase: N/A Priority: Normal
NCT ID: NCT00413387 Org: User:
Start: 09/30/04 End: 10/31/05 Due: 10/31/06

Efficacy and Safety of CUSA-081 in the Restoration of Dysfunctional Central Venous Access Device (CVAD) Functionality

Phase: N/A Priority: Normal
NCT ID: NCT03992443 Org: User:
Start: 02/28/22 End: 03/18/22 Due: 03/18/23

Real-World Effectiveness of a Triple Combination BDP/FF/GB in a Single Pressurised Metered Dose Inhaler in COPD Patients (TRIPHY)

Phase: N/A Priority: Normal
NCT ID: NCT06480890 Org: User:
Start: 07/02/24 End: 10/15/25 Due: 10/15/26

PK Linearity and Steady State PK of CHF 6532 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03942666 Org: User:
Start: 05/10/19 End: 11/22/19 Due: 11/22/20

Lung Bioavailability and Total Systemic Exposure to Beclomethasone17MonoPropionate and Formoterol Across Two Strengths of NEXThaler Inhalation Powder

Phase: N/A Priority: Normal
NCT ID: NCT01738087 Org: User:
Start: 11/30/12 End: 01/31/13 Due: 01/31/14

PK of CHF6001 in Subjects With Mild, Moderate and Severe Renal Impairment vs. Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05431426 Org: User:
Start: 07/29/22 End: 12/27/22 Due: 12/27/23

Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01070524 Org: User:
Start: 01/31/10 End: 07/31/10 Due: 07/31/11

An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03084718 Org: User:
Start: 07/28/17 End: 12/05/18 Due: 12/05/19